Shelly Ahn Im
- INSTRUCTOR Medicine, Endocrinology, Diabetes and Bone Disease
American Board of Internal Medicine
MD, New York University School of Medicine
Residency, Internal Medicine
Mount Sinai Hospital
NYU Langone Medical Center
Shelly Im, a graduate of New York University’s School of Medicine, completed her internship and residency in Internal Medicine at Mount Sinai Hospital and stayed on for an additional year as a hospitalist in the Division of General Medicine. She returned to New York University to pursue her fellowship training in Endocrinology, Diabetes and Metabolism. During her training she participated in research projects involving thyroid disease in pregnancy as well as atypical fractures related to bisphosphonate use.
Currently Dr. Im sees patients at Mount Sinai’s FPA office location, as well as at Mount Sinai Hospital affiliated off-sites in Bay Ridge, Brooklyn and Jackson Heights, Queens. Her clinical interests include Diabetes Mellitus, thyroid disease, thyroid cancer, and osteoporosis.
La Rocca Vieira R, Rosenberg ZS, Allison MB, Im SA, Babb J, Peck V. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy. AJR. American journal of roentgenology 2012 May; 198(5).
Reh A, Chaudhry S, Mendelsohn F, Im S, Rolnitzky L, Amarosa A, Levitz M, Srinivasa S, Krey L, Berkeley AS, Grifo JA, Danoff A. Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle. Fertility and sterility 2011 Mar; 95(3).
O'Byrne JM, Dempsey CB, O'Malley MK, O'Connell FX. Non-specific abdominal pain in pre-menopausal women. Irish journal of medical science 1991 Nov; 160(11).
Markman LH, Allison MB, Rosenberg ZS, Vieira RL, Babb JS, Tejwani NC, Im SA, Peck V. A Retrospective Review of Patients with Atypical Femoral Fractures While on Long-Term Bisphosphonates: Including Pertinent Biochemical and Imaging Studies. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2013 Jan;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Im did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Atran Berg Laboratory Building Floor 4th floor
1428 Madison Avenue
New York, NY 10029
17 E 102nd Street
5th Floor, Area C
New York, NY 10029
- Monday 9:00am - 5:00pm
- 1199 Member Choice
- Beech Street
- Blue Cross/ Blue Shield
- Group Health Insurance (GHI) - HMO
- Group Health Insurance (GHI) - PPO
- HIP Commercial
- HIP Medicare
- Oxford Freedom
- Oxford Liberty
- United Health Care Commercial